Home › Funds › FOSTER DYKEMA CABOT & PARTNERS, LLC › JNJ

FOSTER DYKEMA CABOT & PARTNERS, LLC position in JNJ

JOHNSON & JOHNSON · Health Care

FOSTER DYKEMA CABOT & PARTNERS, LLC reported holding 5,878 shares of JNJ (JOHNSON & JOHNSON) in its Q3 2026 13F filing — a position valued at US$1.6M, representing 0.08% of its reported portfolio and ranking #44 among its reported holdings. FOSTER DYKEMA CABOT & PARTNERS, LLC has disclosed JNJ holdings in 12 of the last 12 reported quarters, going back to Q4 2023.

Latest position (Q3 2026)5.88K sh
Reported value held$1.56M
Portfolio Weight0.08%
First reportedQ4 2023
Last changeAdd
Updated2026-10-31

Last updated: 2026-10-31 · Source: SEC EDGAR Form 13F-HR

How FOSTER DYKEMA CABOT & PARTNERS, LLC's JNJ position evolved

FOSTER DYKEMA CABOT & PARTNERS, LLC first disclosed a stake in JNJ in Q4 2023 at 4,557 shares (US$714K). The position peaked in Q3 2026 at 5,878 shares, worth US$1.6M. Across 12 filings, FOSTER DYKEMA CABOT & PARTNERS, LLC increased the stake 6 time(s), trimmed it 3 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 5,878 shares valued at US$1.6M — an increase of 725 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q4 2023 4.56K $714.26K New
Q1 2024 4.58K $724.83K Add
Q2 2024 4.81K $703.32K Add
Q3 2024 5.72K $927.63K Add
Q4 2024 5.12K $740.60K Reduce
Q1 2025 4.71K $781.44K Reduce
Q2 2025 5.51K $841.96K Add
Q3 2025 6.41K $1.19M Add
Q4 2025 5.15K $1.07M Reduce
Q1 2026 5.15K $1.26M Hold
Q2 2026 5.15K $1.31M Hold
Q3 2026 5.88K $1.56M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 33 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$39.93B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has FOSTER DYKEMA CABOT & PARTNERS, LLC held JNJ?

FOSTER DYKEMA CABOT & PARTNERS, LLC has disclosed JNJ holdings in 12 of the last 12 reported quarters, going back to Q4 2023.

What is FOSTER DYKEMA CABOT & PARTNERS, LLC's current position in JNJ?

As of Q3 2026, FOSTER DYKEMA CABOT & PARTNERS, LLC holds 5.88K shares of JNJ (JOHNSON & JOHNSON), valued at $1.56M, representing 0.08% of its reported portfolio and ranking #44.

Has FOSTER DYKEMA CABOT & PARTNERS, LLC been buying or selling JNJ?

In the latest 13F filing (Q3 2026), FOSTER DYKEMA CABOT & PARTNERS, LLC increased its position in JNJ. The position peaked in Q3 2026 at 5.88K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.